Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists.

The mental health clinician Pub Date : 2024-08-02 eCollection Date: 2024-08-01 DOI:10.9740/mhc.2024.08.253
Amber R Douglass, Ashley Maister, Karen E Moeller, Aaron Salwan, Anuja Vallabh, Kristin Waters, Gregory H Payne
{"title":"Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists.","authors":"Amber R Douglass, Ashley Maister, Karen E Moeller, Aaron Salwan, Anuja Vallabh, Kristin Waters, Gregory H Payne","doi":"10.9740/mhc.2024.08.253","DOIUrl":null,"url":null,"abstract":"<p><p>Deaths related to opioid overdoses continue to climb, and there remains a need for innovative strategies to address this ongoing crisis. Harm reduction (HR), a nonjudgmental philosophy aimed at reducing consequences associated with drug use and other potentially unsafe behavior, has emerged as a compassionate and effective approach. Harm reduction further emphasizes overdose prevention and fosters a shift in perspective that recognizes substance use disorder as a disease and not a moral failing. The tenets of HR collectively advocate for the well-being of individuals who use substances and support any positive change as defined by the individual. Given the high rate of morbidity and mortality associated with substance misuse and barriers or ambivalence to receiving treatment, awareness of and advocacy for HR practice is essential. This manuscript aims to describe evidence-based HR interventions, provide a foundation for the implementation of services, and further promote the importance of providing humanistic care without judgment. As valued members of the multidisciplinary treatment team, Board-Certified Psychiatric Pharmacists should implement and engage in HR services in the settings where people with substance use disorders receive care.</p>","PeriodicalId":101313,"journal":{"name":"The mental health clinician","volume":"14 4","pages":"253-266"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11298032/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The mental health clinician","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9740/mhc.2024.08.253","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Deaths related to opioid overdoses continue to climb, and there remains a need for innovative strategies to address this ongoing crisis. Harm reduction (HR), a nonjudgmental philosophy aimed at reducing consequences associated with drug use and other potentially unsafe behavior, has emerged as a compassionate and effective approach. Harm reduction further emphasizes overdose prevention and fosters a shift in perspective that recognizes substance use disorder as a disease and not a moral failing. The tenets of HR collectively advocate for the well-being of individuals who use substances and support any positive change as defined by the individual. Given the high rate of morbidity and mortality associated with substance misuse and barriers or ambivalence to receiving treatment, awareness of and advocacy for HR practice is essential. This manuscript aims to describe evidence-based HR interventions, provide a foundation for the implementation of services, and further promote the importance of providing humanistic care without judgment. As valued members of the multidisciplinary treatment team, Board-Certified Psychiatric Pharmacists should implement and engage in HR services in the settings where people with substance use disorders receive care.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
探索减低伤害范例:获得委员会认证的精神科药剂师的作用。
与阿片类药物过量相关的死亡人数持续攀升,因此仍然需要创新的策略来应对这一持续的危机。减少危害(HR)是一种非评判性的理念,旨在减少与吸毒和其他潜在不安全行为相关的后果,是一种富有同情心且有效的方法。减低危害进一步强调预防用药过量,并促进观念的转变,将药物使用障碍视为一种疾病,而非道德失范。减低危害的宗旨是共同倡导使用药物的个人的福祉,并支持个人所定义的任何积极改变。鉴于药物滥用导致的高发病率和高死亡率,以及接受治疗的障碍或矛盾心理,对人力资源实践的认识和倡导至关重要。本手稿旨在描述以证据为基础的人文关怀干预措施,为服务的实施奠定基础,并进一步宣传不带评判地提供人文关怀的重要性。作为多学科治疗团队的重要成员,获得委员会认证的精神科药剂师应在药物使用障碍患者接受治疗的环境中实施并参与人力资源服务。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.90
自引率
0.00%
发文量
0
期刊最新文献
Pharmacist administration of long-acting injectable medications for substance use disorders: A scoping review. Impact of weight loss surgery on valproic acid levels: A case report. Potential changes impacting psychiatric pharmacy by 2030. A model for timely dissemination of critical information: Clozapine toxicity during the COVID pandemic. Transitions of care: Assessment of adherence to long-acting injectable antipsychotic treatment following discharge from inpatient psychiatry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1